VerAvanti

Bothell, WA · Founded 2013 · Privately Held (backing)

Developer of a scanning fiber endoscope device designed to identify the causes of strokes and cardiac events. VerAvanti is based in Bothell, WA and was founded in 2013. It was valued at $161 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $43.4 million across 2 recorded rounds; the latest was a $28.3 million early-stage round in Feb 2025.

PMV mark · valuation
$161.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$43.4M
Last round
Early Stage VC
Feb 2025
How much has VerAvanti raised?
$43.4Macross 2 recorded rounds · May 2017 – Feb 2025

Most recently, VerAvanti raised $28.3M in its Early Stage VC (Feb 2025).

Free account
More of VerAvanti with a free account
  • ·Watch VerAvanti: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

VerAvanti round by round

2 rounds
Feb 2025Early Stage VC$28.3MSEC filing▮
17 investors participated
May 2017Seed Round$540KSEC filing▮
5 investors participated

How much has VerAvanti raised?

VerAvanti has raised $43.4 million in total; 2 of its rounds are on record. The largest on record was a $540,000 seed round in May 2017; the most recent was a $28.3 million early-stage round in Feb 2025.

VerAvanti has filed 2 Form Ds with the SEC since 2017, most recently in Mar 2025 ($28.3 million sold to 17 investors).

VerAvanti investors

6 investors are on record for VerAvanti, including Lung, National Cancer Institute, National Heart and UW CoMotion. The early-stage round in Feb 2025 drew 17 investors.

For fundraisers
Raising for a company like VerAvanti?

6 investors have backed VerAvanti.

See all 6 investors →

Frequently asked about VerAvanti

How much has VerAvanti raised?
VerAvanti has raised $43.4M in total across 2 recorded funding rounds.
When was VerAvanti's last funding round?
VerAvanti's most recent recorded round was Early Stage VC in Feb 2025, raising $28.3M.